Source-grounded facts extracted from Nu-Med Plus, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
William Hayde was appointed as President/Chief Executive Officer at Nu-Med Plus, Inc..
“On October 28, 2024, the Board of Directors appointed Mr. William Hayde, who is the Chairman of the Board, to serve as President/Chief Executive Officer of Nu-Med.”
Russ Colvin resigned as President/Chief Executive Officer and Director at Nu-Med Plus, Inc..
“Mr. Colvin submitted his resignation from the positions to which he had been appointed.”
William Hayde was appointed as Executive Chairman of the Board at Nu-Med Plus, Inc..
“Following the appointment of Mr. Colvin as President and Chief Executive Officer, the Company’s former President and CEO William Hayde was appointed to serve as the Company’s Executive Chairman of the Board.”
William R. "Russ" Colvin was appointed as President, Chief Executive Officer, and Director at Nu-Med Plus, Inc..
“the Board of Directors of the Company appointed William R. “Russ” Colvin as the Company’s President, Chief Executive Officer, and Director of the Company.”
Nu-Med Plus, Inc. entered into Share Exchange Agreement with YourSpace America, Inc. (effective 2024-04-25).
“On April 25, 2024, Nu-Med Plus, Inc. (the " Company ") entered into a Share Exchange Agreement (the " Share Exchange Agreement ") for the merger of YourSpace America, Inc. (" YSA ") into the Company (the " Transaction ").”
Nu-Med Plus, Inc. engaged Fruci & Associates as its auditor.
“2 On February 17, 2023, Nu-Med engaged Fruci & Associates. Section 9 Financial Statements and Exhibits”
Nu-Med Plus, Inc. dismissed Sadler, Gibb & Associates, LLC as its auditor.
“On February 17, 2023, Nu-Med Plus, Inc. (“Nu-Med”) dismissed Sadler, Gibb & Associates, LLC as our independent registered public accounting firm.”
Nu-Med Plus, Inc. entered into 5% Convertible Promissory Note with Your Space, Inc. valued at $100,000 (effective 2023-12-31).
“On November 81, 2022, the Company issued a 5% Convertible Promissory Note for $100,000 to Your Space, Inc., that is due December 31, 2023.”
Nu-Med Plus, Inc. entered into 5% Convertible Promissory Note with Your Space, Inc. valued at $100,000 principal, 5% interest, due December 31, 2023 (effective 2022-11-81).
“On November 81, 2022, the Company issued a 5% Convertible Promissory Note for $100,000 to Your Space, Inc., that is due December 31, 2023.”
Jeffrey L. Robins was appointed as Director at Nu-Med Plus, Inc..
“On October 18, 2022, the Board of Directors recognized the need for an additional member of the Board of Directors, and unanimously consented to appoint Jeffrey L. Robins to the Board of Director.”
William Hayde was appointed as President, Chief Executive Officer, Director and Chairman of the Board at Nu-Med Plus, Inc..
“The Corporation has appointed Mr. William Hayde as the President, Chief Executive Officer, Director and Chairman of the Board.”
Dr. Brett J. Earl resigned as Director at Nu-Med Plus, Inc..
“and Dr. Brett J. Earl resigned as a director.”
Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board at Nu-Med Plus, Inc..
“On September 12, 2022, Jeffrey L. Robins resigned as President, Chief Executive Officer, Director and Chairman of the Board”
Dr. Craig Morrison departed as Medical Advisory Board at Nu-Med Plus, Inc..
“Dr. Craig Morrison resigned as Vice President of Research and a director. Dr. Morrison is moving to a position on our Medical Advisory Board.”
William Moon resigned as Vice President of Technology and director at Nu-Med Plus, Inc..
“On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.”
Thomas Tate resigned as Vice President of Scientific Development and director at Nu-Med Plus, Inc..
“On December 31, 2021, Thomas Tate resigned as Vice President of Scientific Development and a director; William Moon resigned as Vice President of Technology and a director; and Dr. Craig Morrison resigned as Vice President of Research and a director.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.